Suchergebnisse - "Lara, Beatriz"

PubPharm (212)

11

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency : EARCO international registry

enthalten in: Respiratory research | 2022

von Miravitlles, M. | Turner, A. | Torres-Duran, M. | +20

ErratumIn: Respir Res. 2023 Feb 18;24(1):57. - PMID 36800958

12

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

enthalten in: Respiratory research | 2022

von Miravitlles, M. | Turner, A. | Torres-Duran, M. | +20

13

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

enthalten in: Respiratory research | 2022

von Miravitlles, M. | Turner, A. | Torres-Duran, M. | +20

14

Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19 : the IONIC trial protocol

enthalten in: BMJ open | 2022

von Sharma, K. | Berry, L. | Vryonis, E. | +8

15

Anti-Doping Knowledge of Students Undertaking Bachelor's Degrees in Sports Sciences in Spain

enthalten in: Nutrients | 2022

von Aguilar-Navarro, M. | Salas-Montoro, J. | Pino-Ortega, J. | +11

16

Effect of caffeine on muscle oxygen saturation during short-term all-out exercise : a double-blind randomized crossover study

enthalten in: European journal of nutrition | 2022

von Ruiz-Moreno, C. | Gutiérrez-Hellín, J. | Lara, B. | +1

17

Favipiravir and/or nitazoxanide : a randomized, double-blind, 2×2 design, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

enthalten in: Trials | 2022

von Smith, T. | Hoyo-Vadillo, C. | Adom, A. | +17

ErratumIn: Trials. 2023 May 22;24(1):347. - PMID 37218017

18

Favipiravir and/or nitazoxanide: a randomized, double-blind, 2×2 design, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

enthalten in: Trials | 2022

von Smith, T. | Hoyo-Vadillo, C. | Adom, A. | +17

19

Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

enthalten in: Trials | 2022

von Smith, T. | Hoyo-Vadillo, C. | Adom, A. | +17

20

Charge effect of water-soluble porphyrin derivatives as a prototype to fight infections caused by Acinetobacter baumannii by aPDT approaches

enthalten in: Biofouling | 2022

von da Silva Canielles Caprara, C. | da Silva Freitas, L. | Iglesias, B. | +2